New Fortress Energy
NFE
Precision Drilling
PDS
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
Halozyme Therapeutics
HALO
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
BHST BioHarvest Sciences
- 6.200
- +0.100+1.64%
Trading Dec 27 11:34 ET
107.43MMarket Cap-5.34P/E (TTM)
6.200High6.100Low4.40KVolume6.130Open6.100Pre Close26.97KTurnover0.04%Turnover RatioLossP/E (Static)17.33MShares7.70052wk High25.94P/B77.91MFloat Cap4.66052wk Low--Dividend TTM12.57MShs Float17.500Historical High--Div YieldTTM1.64%Amplitude4.025Historical Low6.127Avg Price1Lot Size
BioHarvest Sciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -76.78%-1.76M | 66.71%-958K | 4.65%-1.58M | 7.78%-8.52M | -19.57%-2.99M | 60.17%-995K | -65.78%-2.88M | 33.88%-1.66M | -36.02%-9.24M | -9.54%-2.5M |
| Net income from continuing operations | -55.70%-2.69M | 75.89%-687K | -775.13%-6.58M | -11.82%-12.56M | -157.84%-7.24M | 55.99%-1.73M | -19.95%-2.85M | 64.69%-752K | -14.34%-11.24M | -60.07%-2.81M |
| Operating gains losses | 107.88%29K | -543.65%-1.17M | 368.20%5.03M | 493.87%1.55M | 4,314.44%3.97M | -145.94%-368K | -1,106.67%-181K | -204.72%-1.87M | -66.28%261K | -77.16%90K |
| Depreciation and amortization | 61.75%351K | 70.81%357K | 2.02%202K | 17.98%840K | 12.50%216K | 11.86%217K | 10.00%209K | 45.59%198K | 83.03%712K | 39.13%192K |
| Other non cash items | 632.14%410K | -83.56%12K | 116.00%162K | 627.73%866K | 718.69%662K | -78.46%56K | 170.19%73K | 7.14%75K | 109.41%119K | 94.18%-107K |
| Change In working capital | -103.25%-24K | 219.44%344K | -182.12%-496K | 345.13%755K | 13.58%-299K | 2,738.46%738K | -170.24%-288K | 251.76%604K | -220.83%-308K | -349.35%-346K |
| -Change in receivables | -16,800.00%-507K | -141.94%-75K | -239.22%-213K | 96.26%-22K | 61.48%-141K | 92.31%-3K | 41.51%-31K | 217.69%153K | -121.05%-588K | -832.00%-366K |
| -Change in inventory | -656.10%-620K | 180.00%108K | 56.25%-210K | -141.78%-1.09M | -483.33%-391K | -485.71%-82K | 41.56%-135K | -56.35%-480K | 45.65%-450K | 130.27%102K |
| -Change in payables and accrued expense | 34.02%1.1M | 354.92%311K | -107.84%-73K | 155.48%1.87M | 384.15%233K | 941.77%823K | -117.58%-122K | 2,287.18%931K | -26.85%730K | -139.05%-82K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -76.78%-1.76M | 66.71%-958K | 4.65%-1.58M | 7.78%-8.52M | -19.57%-2.99M | 60.17%-995K | -65.78%-2.88M | 33.88%-1.66M | -36.02%-9.24M | -9.54%-2.5M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -7.27%-472K | -426.70%-1.93M | 40.96%-222K | -17.36%-1.47M | -10.65%-291K | -57.71%-440K | -13.62%-367K | 3.84%-376K | 23.41%-1.26M | 25.71%-263K |
| Net PPE purchase and sale | -16.36%-512K | -365.40%-1.71M | 40.96%-222K | -17.36%-1.47M | -10.65%-291K | -57.71%-440K | -13.62%-367K | 3.84%-376K | 23.41%-1.26M | 25.71%-263K |
| Net other investing changes | --40K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -7.27%-472K | -426.70%-1.93M | 40.96%-222K | -17.36%-1.47M | -10.65%-291K | -57.71%-440K | -13.62%-367K | 3.84%-376K | 23.41%-1.26M | 25.71%-263K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -113.86%-164K | -2.97%4.61M | -118.80%-116K | 66.58%13.56M | 214.16%7.01M | -69.15%1.18M | 133.96%4.75M | 1,334.88%617K | -24.45%8.14M | 4,309.43%2.23M |
| Net issuance payments of debt | -113.86%-164K | -102.74%-119K | -120.91%-129K | 80.20%13.15M | 209.04%7.01M | -61.90%1.18M | 114.10%4.34M | 699.03%617K | 2,298.49%7.3M | 2,301.94%2.27M |
| Proceeds from stock option exercised by employees | ---4.33M | 1,072.46%4.73M | --13K | -54.05%403K | --0 | --0 | --403K | --0 | -75.89%877K | --1K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---38K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -113.86%-164K | -2.97%4.61M | -118.80%-116K | 66.58%13.56M | 214.16%7.01M | -69.15%1.18M | 133.96%4.75M | 1,334.88%617K | -24.45%8.14M | 4,309.43%2.23M |
| Net cash flow | ||||||||||
| Beginning cash position | 185.21%5.17M | 1,045.33%3.44M | 208.47%5.36M | -57.83%1.74M | -31.38%1.56M | 49.26%1.81M | -76.30%300K | -57.83%1.74M | 130.90%4.12M | -66.65%2.27M |
| Current changes in cash | -850.40%-2.4M | 14.18%1.72M | -35.50%-1.92M | 250.91%3.56M | 794.78%3.72M | -123.82%-252K | 5,106.67%1.5M | 50.40%-1.41M | -200.90%-2.36M | 80.10%-536K |
| Effect of exchange rate changes | -400.00%-5K | 70.00%17K | 86.36%-3K | 368.18%59K | --72K | ---1K | 145.45%10K | ---22K | -450.00%-22K | --0 |
| End cash Position | 77.55%2.77M | 185.21%5.17M | 1,045.33%3.44M | 208.47%5.36M | 208.47%5.36M | -31.38%1.56M | 49.26%1.81M | -76.30%300K | -57.83%1.74M | -57.83%1.74M |
| Free cash flow | -58.26%-2.27M | 17.84%-2.67M | 11.37%-1.8M | 4.77%-10M | -18.72%-3.29M | 48.33%-1.44M | -57.60%-3.25M | 29.82%-2.03M | -24.46%-10.5M | -4.81%-2.77M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |